US firms call on India to maintain cap-free FDI regime
This article was originally published in Scrip
Executive Summary
US companies across various sectors, including drug firms under the drug industry association PhRMA, are predictably seeking a virtually cap-free foreign direct investment (FDI) regime in India, suggesting that other mechanisms could deal with concerns about investment conduct in the country.A call that is likely to reopen a splitwithin the Indian pharmaceutical industry.